The store will not work correctly when cookies are disabled.
4-(2-Furyl)-2-morpholinyl-1-methyl-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile
ID: ALA2413099
PubChem CID: 45028920
Max Phase: Preclinical
Molecular Formula: C14H14N4O3
Molecular Weight: 286.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cn1c(N2CCOCC2)nc(-c2ccco2)c(C#N)c1=O
Standard InChI: InChI=1S/C14H14N4O3/c1-17-13(19)10(9-15)12(11-3-2-6-21-11)16-14(17)18-4-7-20-8-5-18/h2-3,6H,4-5,7-8H2,1H3
Standard InChI Key: DDBHHWPHROAIOH-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
4.1386 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1386 -12.2719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -12.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -12.2719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5675 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -11.0344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -10.2094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4241 -12.6844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4241 -11.0344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -13.5094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7096 -13.0969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2820 -11.0344 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9965 -11.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7109 -11.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7109 -10.2094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9965 -9.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2820 -10.2094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1856 -13.9943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4406 -14.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2656 -14.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5205 -13.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 1 0
6 7 1 0
2 8 1 0
1 9 2 0
3 10 1 0
8 11 3 0
5 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 12 1 0
10 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 10 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 286.29 | Molecular Weight (Monoisotopic): 286.1066 | AlogP: 0.75 | #Rotatable Bonds: 2 |
Polar Surface Area: 84.29 | Molecular Species: NEUTRAL | HBA: 7 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.17 | CX LogP: -0.07 | CX LogD: -0.07 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.81 | Np Likeness Score: -1.90 |
References
1. Fargualy AM, Habib NS, Ismail KA, Hassan AM, Sarg MT.. (2013) Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives., 66 [PMID:23811090] [10.1016/j.ejmech.2013.05.028] |